alxo: the income statement

MyFinsight

ALX ONCOLOGY HOLDINGS INC (ALXO)

For the quarter ending 2025-06-30, ALXO made $1,106K in revenue. -$25,949K in net income. Net profit margin of -2346.20%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Other income (expense), net	-2
Research and development	18,022
Impairment charge	3,175
General and administrative	5,451
Total operating expenses	26,648
Loss from operations	-26,648
Interest income	1,106
Interest expense	405
Net loss	-25,949

Net loss per share, basic	-0.49
Net loss per share, diluted	-0.49
Weighted-average shares of common stock used to compute net loss per share, basic	53,445,631
Weighted-average shares of common stock used to compute net loss per share, diluted	53,445,631

Unit: Thousand (K) dollars (except for numbers of shares and EPS)